• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    9/15/23 11:52:24 AM ET
    $PLNT
    $PLRX
    $PMF
    $PML
    Hotels/Resorts
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $PLNT alert in real time by email

     

    Friday's session saw 169 companies set new 52-week lows.

    Points of Interest From Today's 52-Week Lows:

    • Bristol-Myers Squibb (NYSE:BMY) was the largest firm by market cap to set a new 52-week low.
    • Blue Star Foods (NASDAQ:BSFC) was the smallest company in terms of market cap to set a new 52-week low.
    • PTC Therapeutics (NASDAQ:PTCT)'s stock fell the most, as it traded down 31.29% to reach a new 52-week low.
    • Prelude Therapeutics (NASDAQ:PRLD)'s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low.

    On Friday, the following stocks set new 52-week lows:

    • Bristol-Myers Squibb (NYSE:BMY) stock dropped to a yearly low on Friday of $58.92. Shares traded down 0.87%.
    • Realty Income (NYSE:O) shares reached a new 52-week low of $54.29 on Friday morning, moving down 1.42%.
    • Illumina (NASDAQ:ILMN) stock hit a yearly low of $145.14. The stock was down 3.41% for the day.
    • ResMed (NYSE:RMD) stock hit $145.74 on Friday morning, setting a new 52-week low for a change of down 0.98%.
    • Royalty Pharma (NASDAQ:RPRX) shares made a new 52-week low of $28.21 on Friday. The stock was down 1.67% for the day.
    • Insulet (NASDAQ:PODD) stock hit $166.03 on Friday morning, setting a new 52-week low for a change of down 3.92%.
    • Chewy (NYSE:CHWY) stock set a new 52-week low of $20.48 on Friday, moving down 2.75%.
    • TKO Group Holdings (NYSE:TKO) shares fell to $99.24 on Friday, setting a new 52-week low with a shift of down 1.27%.
    • SolarEdge Technologies (NASDAQ:SEDG) stock hit a new 52-week low of $141.67. The stock was down 1.29% on the session.
    • Liberty SiriusXM Gr (NASDAQ:LSXMB) shares reached a new 52-week low of $22.19 on Friday morning, moving down 3.38%.
    • Agree Realty (NYSE:ADC) shares set a new 52-week low of $59.51. The stock traded down 0.9%.
    • Envista Holdings (NYSE:NVST) shares made a new 52-week low of $28.74 on Friday. The stock was down 0.62% for the day.
    • Planet Fitness (NYSE:PLNT) stock dropped to a yearly low on Friday of $50.21. Shares traded down 15.17%.
    • Cava Group (NYSE:CAVA) stock broke to a new 52-week low of $34.42 on Friday. Shares of the company traded down 3.66%.
    • Medical Properties Trust (NYSE:MPW) stock achieved a new 52-week low on Friday morning, hitting $6.28 and moving down 3.72%.
    • PNM Resources (NYSE:PNM) stock broke to a new 52-week low of $43.64 on Friday. Shares of the company traded down 0.22%.
    • Savers Value Village (NYSE:SVV) shares fell to $19.61 on Friday, setting a new 52-week low with a shift of down 2.02%.
    • Physicians Realty Trust (NYSE:DOC) shares hit a yearly low of $12.94. The stock was down 3.03% on the session.
    • Macy's (NYSE:M) stock hit $11.15 on Friday morning, setting a new 52-week low for a change of down 1.54%.
    • Tower Semiconductor (NASDAQ:TSEM) stock dropped to a yearly low on Friday of $27.23. Shares traded down 2.22%.
    • Galapagos (NASDAQ:GLPG) stock dropped to a yearly low on Friday of $36.00. Shares traded down 0.11%.
    • PTC Therapeutics (NASDAQ:PTCT) shares set a new yearly low of $24.43 this morning. The stock was down 31.29% on the session.
    • Grupo Televisa (NYSE:TV) stock set a new 52-week low of $3.41 on Friday, moving down 2.01%.
    • Mister Car Wash (NYSE:MCW) shares hit a yearly low of $6.04. The stock was down 1.61% on the session.
    • Peloton Interactive (NASDAQ:PTON) shares hit a yearly low of $4.96. The stock was down 2.43% on the session.
    • Spirit AeroSystems Hldgs (NYSE:SPR) shares were up 1.28% for the day, having made a 52-week low of $16.28.
    • Silicon Motion Technology (NASDAQ:SIMO) shares set a new 52-week low of $50.51. The stock traded down 1.35%.
    • Supernus Pharmaceuticals (NASDAQ:SUPN) shares set a new 52-week low of $28.77. The stock traded down 1.13%.
    • ZIM Integrated Shipping (NYSE:ZIM) shares set a new yearly low of $11.15 this morning. The stock was up 0.45% on the session.
    • Amylyx Pharma (NASDAQ:AMLX) shares set a new yearly low of $19.36 this morning. The stock was up 0.25% on the session.
    • Petco Health and Wellness (NASDAQ:WOOF) stock drifted down 3.78% on Friday morning to hit a new 52-week low of $4.44.
    • Syndax Pharmaceuticals (NASDAQ:SNDX) stock hit a yearly low of $16.76. The stock was down 0.21% for the day.
    • Netstreit (NYSE:NTST) stock broke to a new 52-week low of $16.62 on Friday. Shares of the company traded up 0.3%.
    • Phreesia (NYSE:PHR) stock hit a new 52-week low of $19.52. The stock was down 1.44% on the session.
    • Pliant Therapeutics (NASDAQ:PLRX) shares reached a new 52-week low of $15.82 on Friday morning, moving down 0.56%.
    • Olo (NYSE:OLO) shares set a new 52-week low of $5.63. The stock traded down 0.44%.
    • Definitive Healthcare (NASDAQ:DH) stock set a new 52-week low of $8.07 on Friday, moving down 1.21%.
    • Tekla Healthcare (NYSE:HQH) stock set a new 52-week low of $15.96 on Friday, moving down 0.68%.
    • GDEV (NASDAQ:GDEV) stock achieved a new 52-week low on Friday morning, hitting $3.09 and moving down 9.33%.
    • Gogoro (NASDAQ:GGR) stock drifted down 0.55% on Friday morning to hit a new 52-week low of $2.67.
    • Silk Road Medical (NASDAQ:SILK) stock broke to a new 52-week low of $16.72 on Friday. Shares of the company traded down 1.52%.
    • DocGo (NASDAQ:DCGO) stock drifted down 5.11% on Friday morning to hit a new 52-week low of $5.76.
    • PIMCO Income Strategy (NYSE:PFN) stock broke to a new 52-week low of $6.63 on Friday. Shares of the company traded up 0.15%.
    • FuelCell Energy (NASDAQ:FCEL) stock broke to a new 52-week low of $1.23 on Friday. Shares of the company traded down 3.02%.
    • PIMCO Municipal Income (NYSE:PML) stock achieved a new 52-week low on Friday morning, hitting $8.28 and moving up 0.35%.
    • Nuveen California (NYSE:NKX) stock hit $10.71 on Friday morning, setting a new 52-week low for a change of down 0.28%.
    • Consensus Cloud Solutions (NASDAQ:CCSI) shares set a new yearly low of $25.05 this morning. The stock was down 2.26% on the session.
    • Theravance Biopharma (NASDAQ:TBPH) shares set a new yearly low of $9.05 this morning. The stock was down 5.77% on the session.
    • Lyell Immunopharma (NASDAQ:LYEL) stock set a new 52-week low of $1.66 on Friday, moving down 1.72%.
    • Perfect (NYSE:PERF) stock dropped to a yearly low on Friday of $3.21. Shares traded down 7.28%.
    • Seres Therapeutics (NASDAQ:MCRB) shares moved down 2.2% on Friday to hit a new 52-week low of $2.83, drifting down 2.2%.
    • Eaton Vance Municipal IT (NYSE:EVN) stock hit a yearly low of $9.26. The stock was up 0.22% for the day.
    • Butterfly Network (NYSE:BFLY) shares set a new yearly low of $1.61 this morning. The stock was up 8.57% on the session.
    • Aerovate Therapeutics (NASDAQ:AVTE) stock broke to a new 52-week low of $12.87 on Friday. Shares of the company traded down 5.14%.
    • Materialise (NASDAQ:MTLS) shares fell to $5.96 on Friday, setting a new 52-week low with a shift of down 1.32%.
    • QuantaSing Group (NASDAQ:QSG) shares were down 5.76% for the day, having made a 52-week low of $5.70.
    • TH International (NASDAQ:THCH) stock hit a yearly low of $1.93. The stock was down 2.99% for the day.
    • Expensify (NASDAQ:EXFY) stock set a new 52-week low of $3.56 on Friday, moving down 3.81%.
    • Nuvation Bio (NYSE:NUVB) shares were down 2.17% for the day, having made a 52-week low of $1.33.
    • SkyWater Technology (NASDAQ:SKYT) stock hit a yearly low of $6.06. The stock was down 1.77% for the day.
    • Nuveen Core Plus Impact (NYSE:NPCT) stock hit a new 52-week low of $9.51. The stock was down 0.15% on the session.
    • Citizens Financial Servs (NASDAQ:CZFS) stock broke to a new 52-week low of $49.69 on Friday. Shares of the company traded down 0.14%.
    • PIMCO Municipal Income (NYSE:PMF) shares hit a yearly low of $8.92. The stock was down 0.22% on the session.
    • Axogen (NASDAQ:AXGN) shares made a new 52-week low of $5.30 on Friday. The stock was down 2.44% for the day.
    • Fate Therapeutics (NASDAQ:FATE) shares set a new yearly low of $2.28 this morning. The stock was down 2.54% on the session.
    • Cambium Networks (NASDAQ:CMBM) shares made a new 52-week low of $7.43 on Friday. The stock was down 2.86% for the day.
    • Gossamer Bio (NASDAQ:GOSS) stock broke to a new 52-week low of $0.84 on Friday. Shares of the company traded down 1.68%.
    • eGain (NASDAQ:EGAN) shares set a new yearly low of $5.80 this morning. The stock was down 4.13% on the session.
    • Blackrock Investment (NYSE:BKN) shares hit a yearly low of $10.61. The stock was down 0.38% on the session.
    • SIGNA Sports United (NYSE:SSU) shares moved down 6.3% on Friday to hit a new 52-week low of $0.45, drifting down 6.3%.
    • PIMCO CA Muni Income Fund (NYSE:PCK) shares hit a yearly low of $5.44. The stock was down 0.7% on the session.
    • Prelude Therapeutics (NASDAQ:PRLD) stock drifted 0.0% (flat) on Friday morning to hit a new 52-week low of $3.07.
    • CoreCard (NYSE:CCRD) shares set a new yearly low of $20.01 this morning. The stock was down 0.74% on the session.
    • XIAO-I (NASDAQ:AIXI) shares fell to $2.17 on Friday, setting a new 52-week low with a shift of down 2.01%.
    • Gabelli Healthcare (NYSE:GRX) shares set a new yearly low of $9.10 this morning. The stock was down 0.22% on the session.
    • Skillz (NYSE:SKLZ) stock dropped to a yearly low on Friday of $6.32. Shares traded down 0.93%.
    • Zentek (NASDAQ:ZTEK) stock dropped to a yearly low on Friday of $1.19. Shares traded up 3.23%.
    • Lazydays Hldgs (NASDAQ:LAZY) shares set a new yearly low of $9.13 this morning. The stock was down 8.46% on the session.
    • Flaherty & Crumrine Prefd (NYSE:PFD) stock achieved a new 52-week low on Friday morning, hitting $9.41 and moving up 0.53%.
    • China Automotive Systems (NASDAQ:CAAS) stock drifted down 3.09% on Friday morning to hit a new 52-week low of $3.67.
    • NGM Biopharmaceuticals (NASDAQ:NGM) stock dropped to a yearly low on Friday of $1.29. Shares traded up 2.29%.
    • Honest Co (NASDAQ:HNST) stock hit $1.11 on Friday morning, setting a new 52-week low for a change of down 15.6%.
    • ContextLogic (NASDAQ:WISH) shares fell to $4.44 on Friday, setting a new 52-week low with a shift of down 1.74%.
    • Vacasa (NASDAQ:VCSA) stock broke to a new 52-week low of $0.40 on Friday. Shares of the company traded up 1.26%.
    • BioAtla (NASDAQ:BCAB) shares reached a new 52-week low of $2.03 on Friday morning, moving up 0.49%.
    • Sezzle (NASDAQ:SEZL) shares hit a yearly low of $14.01. The stock was down 7.2% on the session.
    • FibroGen (NASDAQ:FGEN) shares set a new yearly low of $0.88 this morning. The stock was down 2.54% on the session.
    • OFS Credit Co (NASDAQ:OCCI) shares made a new 52-week low of $7.26 on Friday. The stock was down 0.71% for the day.
    • GABELLI CONVERTIBLE (NYSE:GCV) shares made a new 52-week low of $3.73 on Friday. The stock was up 0.53% for the day.
    • Clene (NASDAQ:CLNN) shares made a new 52-week low of $0.56 on Friday. The stock was down 5.51% for the day.
    • Rani Therapeutics Hldgs (NASDAQ:RANI) shares fell to $2.80 on Friday, setting a new 52-week low with a shift of down 4.11%.
    • Spectral AI (NASDAQ:MDAI) shares were down 6.3% for the day, having made a 52-week low of $3.60.
    • Zapp Electric Vehicles (NASDAQ:ZAPP) stock hit a yearly low of $1.22. The stock was down 6.15% for the day.
    • Personalis (NASDAQ:PSNL) shares set a new 52-week low of $1.37. The stock traded down 0.77%.
    • Sol-Gel Technologies (NASDAQ:SLGL) stock set a new 52-week low of $2.16 on Friday, moving down 0.4%.
    • GEN Restaurant Gr (NASDAQ:GENK) shares made a new 52-week low of $12.59 on Friday. The stock was down 3.55% for the day.
    • Eargo (NASDAQ:EAR) stock hit a new 52-week low of $2.44. The stock was up 0.81% on the session.
    • Mira Pharmaceuticals (NASDAQ:MIRA) stock achieved a new 52-week low on Friday morning, hitting $3.41 and moving down 3.94%.
    • Brainstorm Cell (NASDAQ:BCLI) stock hit a yearly low of $0.95. The stock was down 5.0% for the day.
    • Lantern Pharma (NASDAQ:LTRN) shares set a new 52-week low of $4.00. The stock traded down 3.94%.
    • Prestige Wealth (NASDAQ:PWM) stock broke to a new 52-week low of $4.50 on Friday. Shares of the company traded down 4.88%.
    • Leap Therapeutics (NASDAQ:LPTX) stock hit a yearly low of $1.60. The stock was down 2.12% for the day.
    • Liberty TripAdvisor Hldgs (NASDAQ:LTRPA) shares were down 1.68% for the day, having made a 52-week low of $0.52.
    • Brilliant Earth Group (NASDAQ:BRLT) stock hit a yearly low of $3.07. The stock was down 2.82% for the day.
    • Enlivex Therapeutics (NASDAQ:ENLV) shares reached a new 52-week low of $1.72 on Friday morning, moving down 4.77%.
    • PIMCO New York Municipal (NYSE:PYN) stock achieved a new 52-week low on Friday morning, hitting $5.67 and moving up 0.18%.
    • Solowin Holdings (NASDAQ:SWIN) stock hit a new 52-week low of $2.27. The stock was down 10.04% on the session.
    • Koss (NASDAQ:KOSS) stock broke to a new 52-week low of $3.35 on Friday. Shares of the company traded down 2.31%.
    • RF Industries (NASDAQ:RFIL) shares hit a yearly low of $2.92. The stock was down 18.11% on the session.
    • SEALSQ (NASDAQ:LAES) shares fell to $3.05 on Friday, setting a new 52-week low with a shift of down 6.39%.
    • Sunworks (NASDAQ:SUNW) stock broke to a new 52-week low of $0.68 on Friday. Shares of the company traded down 3.48%.
    • IN8bio (NASDAQ:INAB) shares were down 0.53% for the day, having made a 52-week low of $0.90.
    • OncoCyte (NASDAQ:OCX) shares set a new 52-week low of $3.18. The stock traded up 2.13%.
    • Alpine 4 Holdings (NASDAQ:ALPP) stock set a new 52-week low of $0.91 on Friday, moving down 2.79%.
    • VBI Vaccines (NASDAQ:VBIV) stock set a new 52-week low of $1.01 on Friday, moving down 2.75%.
    • Protara Therapeutics (NASDAQ:TARA) shares set a new 52-week low of $2.05. The stock traded down 0.45%.
    • Cyngn (NASDAQ:CYN) shares made a new 52-week low of $0.50 on Friday. The stock was down 7.89% for the day.
    • Phoenix New Media (NYSE:FENG) shares reached a new 52-week low of $1.12 on Friday morning, moving down 0.83%.
    • Vaccinex (NASDAQ:VCNX) shares set a new 52-week low of $0.17. The stock traded down 8.97%.
    • EZGO Technologies (NASDAQ:EZGO) shares reached a new 52-week low of $0.16 on Friday morning, moving down 3.61%.
    • PolyPid (NASDAQ:PYPD) shares fell to $0.24 on Friday, setting a new 52-week low with a shift of down 7.49%.
    • Intrusion (NASDAQ:INTZ) stock achieved a new 52-week low on Friday morning, hitting $0.50 and moving down 4.61%.
    • Talis Biomedical (NASDAQ:TLIS) shares hit a yearly low of $5.79. The stock was down 4.99% on the session.
    • Remark Hldgs (NASDAQ:MARK) shares moved down 1.59% on Friday to hit a new 52-week low of $0.51, drifting down 1.59%.
    • Inhibikase Therapeutics (NASDAQ:IKT) stock broke to a new 52-week low of $1.65 on Friday. Shares of the company traded up 1.19%.
    • BioCardia (NASDAQ:BCDA) shares hit a yearly low of $0.39. The stock was down 0.28% on the session.
    • Addentax Group (NASDAQ:ATXG) stock hit a new 52-week low of $1.61. The stock was down 3.55% on the session.
    • Tempo Automation Holdings (NASDAQ:TMPO) stock dropped to a yearly low on Friday of $0.20. Shares traded down 2.86%.
    • ContraFect (NASDAQ:CFRX) stock hit a new 52-week low of $0.58. The stock was up 0.24% on the session.
    • Super League Enterprise (NASDAQ:SLE) shares set a new yearly low of $1.57 this morning. The stock was down 11.82% on the session.
    • Antelope Ent Hldgs (NASDAQ:AEHL) stock drifted down 6.12% on Friday morning to hit a new 52-week low of $0.30.
    • PaxMedica (NASDAQ:PXMD) shares set a new yearly low of $0.25 this morning. The stock was down 5.84% on the session.
    • ABVC BioPharma (NASDAQ:ABVC) stock hit a yearly low of $1.03. The stock was up 0.93% for the day.
    • Netcapital (NASDAQ:NCPL) stock broke to a new 52-week low of $0.42 on Friday. Shares of the company traded down 16.89%.
    • Siyata Mobile (NASDAQ:SYTA) shares reached a new 52-week low of $2.11 on Friday morning, moving down 3.77%.
    • Applied UV (NASDAQ:AUVI) shares set a new yearly low of $0.45 this morning. The stock was down 4.26% on the session.
    • Scinai Immunotherapeutics (NASDAQ:SCNI) shares fell to $0.95 on Friday, setting a new 52-week low with a shift of down 15.0%.
    • Baudax Bio (NASDAQ:BXRX) shares set a new 52-week low of $0.34. The stock traded down 2.53%.
    • RiceBran Tech (NASDAQ:RIBT) stock hit a yearly low of $0.45. The stock was down 7.16% for the day.
    • Allarity Therapeutics (NASDAQ:ALLR) shares were down 4.0% for the day, having made a 52-week low of $0.96.
    • Recruiter.Com Group (NASDAQ:RCRT) shares reached a new 52-week low of $1.42 on Friday morning, moving down 3.9%.
    • Blue Star Foods (NASDAQ:BSFC) stock set a new 52-week low of $0.35 on Friday, moving down 6.09%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $PLNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PLNT
    $PLRX
    $PMF
    $PML

    CompanyDatePrice TargetRatingAnalyst
    Envista Holdings Corporation
    $NVST
    2/6/2026$35.00Market Perform → Outperform
    Leerink Partners
    Peloton Interactive Inc.
    $PTON
    2/6/2026$8.00 → $6.00Market Perform
    Telsey Advisory Group
    Healthpeak Properties Inc.
    $DOC
    2/5/2026Buy → Hold
    Argus
    CAVA Group Inc.
    $CAVA
    2/5/2026$80.00Buy
    The Benchmark Company
    Realty Income Corporation
    $O
    1/30/2026$67.00Sector Perform → Sector Outperform
    Scotiabank
    Royalty Pharma plc
    $RPRX
    1/30/2026$49.00Neutral → Buy
    UBS
    PTC Therapeutics Inc.
    $PTCT
    1/28/2026$119.00Overweight
    Barclays
    Gossamer Bio Inc.
    $GOSS
    1/28/2026$9.00Overweight
    Barclays
    More analyst ratings

    $PLNT
    $PLRX
    $PMF
    $PML
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for REVUFORJ issued to SYNDAX PHARMACEUTICALS INC

    Submission status for SYNDAX PHARMACEUTICALS INC's drug REVUFORJ (ORIG-1) with active ingredient REVUMENIB has changed to 'Approval' on 11/15/2024. Application Category: NDA, Application Number: 218944, Application Classification: Type 1 - New Molecular Entity

    11/18/24 9:22:42 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    September 26, 2024 - FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

    For Immediate Release: September 26, 2024 Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.   “Schizophrenia is a leading

    9/26/24 6:42:20 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Altman Peter bought $5,650 worth of shares (5,000 units at $1.13), increasing direct ownership by 2% to 273,866 units (SEC Form 4)

    4 - BioCardia, Inc. (0000925741) (Issuer)

    2/4/26 5:47:41 PM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Opaleye Management Inc. bought $5,800 worth of Ordinary Shares (100 units at $58.00) (SEC Form 4)

    4 - Sol-Gel Technologies Ltd. (0001684693) (Issuer)

    2/4/26 4:05:33 PM ET
    $SLGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Opaleye Management Inc. bought $5,705 worth of Ordinary Shares (100 units at $57.05) (SEC Form 4)

    4 - Sol-Gel Technologies Ltd. (0001684693) (Issuer)

    1/29/26 4:16:32 PM ET
    $SLGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Addentax Group Corp. Announces Proposed Acquisition of Artificial Intelligence (AI)-empowered and Crypto-enabled Asset Management Platform, with Potential to Generate Approximately HKD 300 Million in Revenue

    SHENZHEN, China, Feb. 6, 2026 /PRNewswire/ -- Addentax Group Corp. (NASDAQ:ATXG) (the "Company", "ATXG", "we", "us" or "our") today announced the proposed strategic acquisition of the offshore wealth management and integrated cross-border service business of Hong Kong-based Riches Group, a provider of global asset allocation and cross-border services. The Company believes that, if completed, the proposed acquisition would support the Company's global expansion strategy by facilitating the integration of Riches Group's offshore business ecosystem, AI-enabled financial solutions, and digital currency/crypto service offerings. Based on preliminary internal estimates and subject to final closing

    2/6/26 9:20:00 AM ET
    $ATXG
    Professional Services
    Consumer Discretionary

    AI Model Advancements Do Not Alter the Quantum Threat Model — They Reinforce the Need for SEALSQ Type of Post-Quantum Secure Infrastructure

    Geneva, Switzerland, Feb. 06, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ:LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced that while recent developments in advanced enterprise AI systems, including Anthropic's release of Claude Opus 4.6, represent a significant evolution in large-scale classical artificial intelligence, these developments do not introduce any material change to the quantum computing threat landscape nor to the technical requirements for quantum-secure cryptographic architectures. Claude Opus 4.6 is a classical large language model operating ent

    2/6/26 8:45:00 AM ET
    $LAES
    Semiconductors
    Technology

    Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025

    Fourth quarter 2025 results: Revenue of $1.16 billion, up 5% from Q4 2024 (up 4% on a constant currency basis)Ex-China revenue of $1.10 billion, up 8% from Q4 2024 (up 7% on a constant currency basis)GAAP operating margin of 17.4% and non-GAAP operating margin of 23.7%GAAP diluted EPS of $2.16 and non-GAAP diluted EPS of $1.35Fiscal year 2025 results: Revenue of $4.34 billion, flat compared to 2024 on both a reported and constant currency basisEx-China revenue of $4.10 billion, up 2% from 2024 on both a reported and constant currency basisGAAP operating margin of 18.6% and non-GAAP operating margin of 23.1%GAAP diluted EPS of $5.45 and non-GAAP diluted EPS of $4.84Fiscal year 2026 guidance:

    2/5/26 4:06:00 PM ET
    $ILMN
    Medical Specialities
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Envista upgraded by Leerink Partners with a new price target

    Leerink Partners upgraded Envista from Market Perform to Outperform and set a new price target of $35.00

    2/6/26 8:05:48 AM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Telsey Advisory Group reiterated coverage on Peloton with a new price target

    Telsey Advisory Group reiterated coverage of Peloton with a rating of Market Perform and set a new price target of $6.00 from $8.00 previously

    2/6/26 6:46:09 AM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Healthpeak Properties downgraded by Argus

    Argus downgraded Healthpeak Properties from Buy to Hold

    2/5/26 8:46:47 AM ET
    $DOC
    Real Estate Investment Trusts
    Real Estate

    $PLNT
    $PLRX
    $PMF
    $PML
    SEC Filings

    View All

    $PLNT
    $PLRX
    $PMF
    $PML
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    BioAtla Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure

    8-K - BioAtla, Inc. (0001826892) (Filer)

    2/6/26 5:02:26 PM ET
    $BCAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 8-K filed by Netcapital Inc.

    8-K - Netcapital Inc. (0001414767) (Filer)

    2/6/26 4:30:23 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    Addentax Group Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - ADDENTAX GROUP CORP. (0001650101) (Filer)

    2/6/26 9:15:29 AM ET
    $ATXG
    Professional Services
    Consumer Discretionary

    Chief Executive Officer Metzger Michael A was granted 217,600 shares and sold $152,835 worth of shares (7,412 units at $20.62), increasing direct ownership by 70% to 508,849 units (SEC Form 4)

    4 - Syndax Pharmaceuticals Inc (0001395937) (Issuer)

    2/6/26 5:54:06 PM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Goldan Keith A. acquired $10,337 worth of shares (1,219 units at $8.48), was granted 52,250 shares and sold $42,931 worth of shares (2,082 units at $20.62), increasing direct ownership by 56% to 143,839 units (SEC Form 4)

    4 - Syndax Pharmaceuticals Inc (0001395937) (Issuer)

    2/6/26 5:53:43 PM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Jarrett Jennifer was granted 24,000 shares, increasing direct ownership by 27% to 114,000 units (SEC Form 4)

    4 - Syndax Pharmaceuticals Inc (0001395937) (Issuer)

    2/6/26 5:16:26 PM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Led to the Purchase at Aerovate Therapeutics Inc. on Jun 20?

    Recently, on June 20, 2024, a notable insider purchase was made at Aerovate Therapeutics Inc. Director Ra Capital Management, L.P. bought $1,549,944 worth of shares, acquiring 928,110 units at $1.67 per share as reported in the SEC Form 4. Insider transactions like these are closely watched by investors as they can provide valuable insights into the company's prospects. When analyzing insider transactions, it is essential to look for patterns and trends among multiple transactions to gauge the overall sentiment within the company. Several other SEC Form 4 filings were made around the same time, on June 7, 2024, by various insiders at Aerovate Therapeutics Inc. These included transactions by

    6/21/24 3:23:59 PM ET
    $AVTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Protara Therapeutics Inc.

    SC 13G - Protara Therapeutics, Inc. (0001359931) (Subject)

    12/17/24 4:02:03 PM ET
    $TARA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Nuveen Core Plus Impact Fund

    SC 13D/A - Nuveen Core Plus Impact Fund (0001835068) (Subject)

    12/16/24 6:56:51 PM ET
    $NPCT
    Investment Managers
    Finance

    SEC Form SC 13D filed by Prestige Wealth Inc.

    SC 13D - Prestige Wealth Inc. (0001765850) (Subject)

    12/13/24 5:00:03 PM ET
    $PWM
    Finance: Consumer Services
    Finance

    $PLNT
    $PLRX
    $PMF
    $PML
    Leadership Updates

    Live Leadership Updates

    View All

    PALMETTO APPOINTS LIZ CODDINGTON AS CHIEF FINANCIAL OFFICER

    Peloton CFO brings deep experience scaling consumer and technology-driven businesses to expand access to affordable, reliable energy CHARLOTTE, N.C., Feb. 5, 2026 /PRNewswire/ -- Palmetto, America's leading consumer energy platform, today announced the appointment of Liz Coddington as Chief Financial Officer, effective March 30th, 2026. Coddington will join Palmetto at the close of her four-year tenure as Chief Financial Officer of Peloton Interactive, Inc. (NASDAQ:PTON), where she is currently leading the company's global finance organization during a pivotal period of tran

    2/5/26 8:47:00 AM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Petco Announces Completion of Refinancing and Glenn Murphy's Transition to Chairman

    SAN DIEGO, Feb. 2, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today announced the successful closing of the previously announced long-term debt refinancing and the transition of Glenn Murphy, Executive Chairman of Petco, to Chairman of the Board of Directors, effective February 1. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> Joel Anderso

    2/2/26 4:15:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Sezzle Announces Chief Financial Officer Transition

    Minneapolis, MN, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Sezzle, a purpose-driven digital payment platform, today announced the appointment of Lee Brading as Chief Financial Officer ("CFO"), effective February 1, 2026. Brading will succeed Karen Hartje, who served as CFO and principal financial officer under a Consulting Agreement since November 1, 2025, following her announcement of retirement after nearly eight years as CFO of Sezzle. Hartje will remain engaged as a consultant to ensure an orderly transition.  "Karen has been instrumental in Sezzle's evolution from a private startup to a publicly traded, profitable fintech company," said Char

    1/29/26 4:14:17 PM ET
    $SEZL
    Real Estate

    $PLNT
    $PLRX
    $PMF
    $PML
    Financials

    Live finance-specific insights

    View All

    Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025

    Fourth quarter 2025 results: Revenue of $1.16 billion, up 5% from Q4 2024 (up 4% on a constant currency basis)Ex-China revenue of $1.10 billion, up 8% from Q4 2024 (up 7% on a constant currency basis)GAAP operating margin of 17.4% and non-GAAP operating margin of 23.7%GAAP diluted EPS of $2.16 and non-GAAP diluted EPS of $1.35Fiscal year 2025 results: Revenue of $4.34 billion, flat compared to 2024 on both a reported and constant currency basisEx-China revenue of $4.10 billion, up 2% from 2024 on both a reported and constant currency basisGAAP operating margin of 18.6% and non-GAAP operating margin of 23.1%GAAP diluted EPS of $5.45 and non-GAAP diluted EPS of $4.84Fiscal year 2026 guidance:

    2/5/26 4:06:00 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Envista Reports Fourth Quarter 2025 Results

    BREA, Calif., Feb. 5, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the quarter ended December 31, 2025. "With our disciplined focus on Growth, Operations, and People, Q4 2025 marked another quarter of continued progress for Envista," said Paul Keel, CEO.  "We delivered 10.8% core revenue growth and 22% adjusted EBITDA growth in Q425, and 6.5% core revenue growth and 26% EBITDA growth for the full-year 2025.  In the process, we posted positive growth in all major businesses and geographies, made broad-based improvements in employee d

    2/5/26 4:05:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Savers Value Village, Inc. Fourth Quarter and Fiscal Year 2025 Financial Results To Be Released Thursday, February 19, 2026

    Savers Value Village, Inc. (the "Company") today announced that it plans to report its fourth quarter and fiscal year 2025 financial results on February 19, 2026 after market close. On the same day, the Company will host a conference call at 4:30 p.m. ET to discuss its financial results. Investors and analysts who wish to participate in the call are invited to dial +1 800 549 8228 (international callers, please dial +1 289 819 1520) approximately 10 minutes prior to the start of the call. Please reference Conference ID 57467 when prompted. A live webcast of the conference call will be available in the investor relations section of the Company's website, Savers Value Village - Investor Rel

    2/5/26 4:05:00 PM ET
    $SVV
    Other Specialty Stores
    Consumer Discretionary